These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 854906
1. [Factor VIII inhibitor in multitransfused hemophiliacs. A finding of varying therapeutic consequences]. Ly B, Evensen SA, Stavem P. Tidsskr Nor Laegeforen; 1977 Apr 30; 97(12):554-6, 8. PubMed ID: 854906 [No Abstract] [Full Text] [Related]
2. [Preliminary experience with achieving immune tolerance in patients with hemophilia A and circulating factor VIII inhibitor]. Scharf R, Kucharski W, Lopaciuk S, Celińska W, Dmytrow A, Domański K, Gonet S, Miastkowski Z, Nowakowska I, Przybylski A. Acta Haematol Pol; 1991 Apr 30; 22(1):92-9. PubMed ID: 1823972 [Abstract] [Full Text] [Related]
3. Immune response induced by porcine factor VIII in severe hemophiliacs with antibody to F VIII. Verroust F, Allain JP. Thromb Haemost; 1982 Oct 29; 48(2):238. PubMed ID: 6817447 [No Abstract] [Full Text] [Related]
12. Kinetics of the inhibitor of factor VIII:C in patients with hemophilia A. A study of the cooperative group of hemophilia. Ambriz-Fernández R, Reyna-Fregoso MP, Pizzuto-Chávez J, Rodríguez-Moyado H, Farfán-Canto JM, Trueba-Christy E, Collazo-Jaloma J. Arch Invest Med (Mex); 1985 Jul 29; 16(3):225-35. PubMed ID: 3938639 [No Abstract] [Full Text] [Related]
13. [Incidence of the appearance of factor VIII inhibitor in patients with hemophilia A at the Hemophilia Center of the Clinical Hospital Center in Zagreb]. Ficović P, Tiefenbach A, Brkljacić V, Grgić Z. Lijec Vjesn; 1983 Oct 29; 105(10):410-1. PubMed ID: 6418997 [No Abstract] [Full Text] [Related]
14. [Safe and cost-conscious supply of factor-VIII-deficient Swiss hemophiliacs with AHF preparations]. Stampfli K. Ther Umsch; 1977 Oct 29; 34(10):717-24. PubMed ID: 918896 [No Abstract] [Full Text] [Related]
15. Hemophilic patients with an inhibitor to factor VIII treated with high dose factor VIII concentrate. Results of a collaborative study for the evaluation of factor VIII inhibitor titer, recovery and half life of infused factor VIII. Sultan Y, White GC, Aronstam A, Bosser C, Brackmann HH, Brochier G, Gormsen J, Mariani G, Roberts HR, Scarabin Y. Nouv Rev Fr Hematol (1978); 1986 Oct 29; 28(2):85-9. PubMed ID: 3090516 [Abstract] [Full Text] [Related]
16. The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experience. Brettler DB, Forsberg AD, Levine PH, Aledort LM, Hilgartner MW, Kasper CK, Lusher JM, McMillan C, Roberts H. Arch Intern Med; 1989 Jun 29; 149(6):1381-5. PubMed ID: 2499293 [Abstract] [Full Text] [Related]
18. [Hemophilia A with factor VIII inhibitor]. Shima M. Rinsho Ketsueki; 2003 Feb 29; 44(2):90-101. PubMed ID: 12692981 [No Abstract] [Full Text] [Related]